Skip to content

Posts tagged ‘global health’

Celebrating 70 years of global health research in The Gambia

A symposium last month, to mark the 70th anniversary of MRC Unit The Gambia, revealed how much progress has been made in global health – and how much remains to be done. Pauline Mullin, the MRC’s Partnership Communications Manager for the unit, was there to find out.

Delegates at MRC Unit The Gambia 70th Anniversary Symposium

Professor Umberto D’Alessandro, MRC Unit The Gambia Director, with delegates at the 70th Anniversary Symposium

Read more

GCRF: don’t judge a book by its cover (or title)

In 2016, the then-government introduced a new approach to funding science and research targeted at urgent problems being faced by people the world over: the Global Challenges Research Fund (GCRF), which the MRC helps to deliver. Rachael Sara-Kennedy, Head of International Partnerships at Universities UK, says we must look beyond the face value of overseas research funding to see how it benefits us all.

The GCRF enables our universities and world-class research base to access resources drawn from the government’s overseas aid budget – the Official Development Assistance (ODA) funding to help fight global challenges. The fund represents a not insignificant slice of the government’s commitment to spend 0.7% GDP on overseas aid.

Read more

Working life: Dr Pauline Williams

Dr Pauline Williams leads global health research and development at GSK and recently became an MRC Council member. Here she tells us about mixing science with business, and the satisfaction of making a life-saving gel from an antiseptic mouthwash.

Dr Pauline Williams, Senior VP and Head of Global Health Research and Development at GlaxoSmithKline and MRC Council member

Dr Pauline Williams, GlaxoSmithKline. Image credit: GlaxoSmithKline

Career in brief:

  • Medicine degree, University of Cardiff
  • Clinical Pharmacology physician, Glaxo Phase I Unit
  • Head of Academic Discovery Performance Unit, GSK
  • Senior Vice President and Head of Global Health R&D, GSK

It was the rigour and excitement of early drug development that tempted me away from medicine. I did a stint at a Phase I Clinical Pharmacology Unit after my medical training – and following that I was enticed by an offer to join Glaxo (now GSK) where I’ve worked ever since. My first role was a full immersion in the design, conduct and reporting of experimental medicine studies which has stood me in good stead throughout my career.

Read more